Fundz

Alphageneron Pharmaceuticals reported raising $250,000 in an initial SEC Form D filing, from an offering of $250,000

PRIVATEAug 14, 2023

Amount Raised

$250,000

$250,000 sold, per SEC Form D (first sale Jun 20, 2023)

Round Type

Venture

New YorkHealthcare

Who to call at Alphageneron Pharmaceuticals, and when

A new round usually means Alphageneron Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Alphageneron Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Alphageneron Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Alphageneron Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Alphageneron Pharmaceuticals

Location

1441 BROADWAY, 3RD FLOOR

New York, New York, United States

About

Alphageneron Pharmaceuticals Inc., (“Alphageneron”) is a private clinical stage biopharmaceutical company advancing Natural Killer Cell (“NK Cell”) immunotherapies for hematologic cancers or solid tumors; and, viral infections (including COVID-19). Our seasoned team of biopharmaceutical executives, scientists and clinicians, in the United States and Europe, bringing decades of experience, will be an integral element to the success of our Company.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Alphageneron Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Alphageneron Pharmaceuticals's next move

See what Strategic adds

Alphageneron Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.